Zadek Osteotomy for Treatment of Haglund's Syndrome
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Haglund's Disease. Basic parameters: 18 years — 60 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
Haglund's syndrome is an abnormality of the bone and soft tissues in the foot. An enlargement of the bony section of the heel (where the Achilles tendon is inserted) triggers this condition. * symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport * Zadek described the Zadek Osteotomy option for the treatment of Haglund's syndrome This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the Achilles tendon \- It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy * This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome
Detailed description
Introduction
* In 1928, Patrick Haglund described the Haglund syndrome firstly. Haglund's syndrome is an abnormality of the bone and soft tissues in the foot. An enlargement of the bony section of the heel (where the Achilles tendon is inserted) triggers this condition. The soft tissue near the back of the heel can become irritated when the large, bony lump rubs against rigid shoes. * symptom includes insertional Achilles tendinopathy (IAT), The patient with HS often has a red, irritated, painful heel. And they often complain the enlargement of the posterior heel, which make it more difficult to footwear or sport. * There are many conservative treatment options to treat it, which contains rest, activity modification, ice, or footwear modification. * When these treatment for more than 6 months has failed, surgical options will be considered. * Common surgical methods, including Haglund deformity debridement, endoscopic calcaneoplasty, and Zadek osteotomy (ZO). * Zadek described the ZO option for the treatment of HS firstly. It was later modified by Keck and ZO is a dorsal closing wedge calcaneal osteotomy that allows the tuberosity of Haglund deformity to be brought forward. This operation can change the calcaneus' anatomical length and elevate the distal insertion point of the AT.
Aim of the work
• This study aims to evaluate short term clinical, radiological and functional outcomes of Zadek osteotomy for treatment of Haglund's syndrome.
Patients and Methods
* It is a prospective case series study that will be done in Orthopedics and Traumatology department of Sohag university hospitals on patients suffering from Haglund's syndrome and treated by Zadek osteotomy * We are aiming in this study to include patients within period between 4/2025 to 10/2025
Primary outcome measures
- Primary outcomes for a Zadek osteotomy in Haglund's syndrome include: pain relief. [Time frame: From enrollment and follow up to the end of 24 weeks]
- functional improvement (measured by score VISA-A). [Time frame: From enrollment and follow up to the end of 24 weeks]
- radiological changes to the calcaneus [Time frame: From enrollment and follow up to the end of 24 weeks]
- improved ankle motion (dorsiflexion), [Time frame: From enrollment and follow up to the end of 24 weeks]
- Patient Satisfaction: [Time frame: From enrollment and follow up to the end of 24 weeks]
Eligibility criteria
Inclusion criteria
- patients over 18 years of age and less than 60 Yrs
- All patients had at least six months of conservative treatment
Exclusion criteria
- patients below 18 years of age and more than 60 Yrs
- patients of Haglund's syndrome with AT rupture or degeneration
- uncontrolled diabetic patients with or without neuropathic joint destruction,
- Infection such as osteomyelitis.
- Charcot joint.
- Peripheral vascular disease
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Other
Study locations
Egypt · 1 center
- Faculty of medicine, Sohag University — Sohag
Identifiers
NCT: NCT07157319 · soh-Med--25-8-2MS